STOCK TITAN

Pinnacle Food Group Limited Achieves Laboratory-Scale Astaxanthin Extraction in Haematococcus pluvialis Program

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Pinnacle Food Group (NASDAQ:PFAI) achieved laboratory-scale astaxanthin extraction through its Canadian subsidiary’s microalgae research program at its Vancouver laboratory.

The workflow progressed from strain screening through culture expansion, stress induction and astaxanthin accumulation to extraction from cultivated biomass. Cultivation used a 500-liter photobioreactor, followed by laboratory-scale extraction using an in-house process. Pinnacle Food plans further research to optimize the process and evaluate whether it can be scaled up. Results remain at laboratory scale, and further work is required before commercial viability can be assessed.

Loading...
Loading translation...

Positive

  • Minor pointLaboratory-scale astaxanthin extraction completed the research workflow from strain screening through extraction from cultivated biomass.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Further research planned to optimize the process and evaluate scale-up feasibility.

Negative

  • Minor pointResults remain at laboratory scale; further work is required before commercial viability can be assessed.

Key Figures

Photobioreactor capacity: 500-liter
Photobioreactor capacity
500-liter
Cultivation for the laboratory-scale astaxanthin extraction program

Historical Context

1 past event · Latest: Jul 15
1 event
  1. Jul 15

    astaxanthin facility

    24h Move
    +4.8%

    Earlier disclosure described a commercial-scale astaxanthin facility project for Bei Harvest, with phased construction.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

astaxanthin, photobioreactor, carotenoid
3 terms
astaxanthin technical
"successfully achieved astaxanthin extraction at laboratory scale"
Astaxanthin is a red pigment and powerful antioxidant produced by certain algae and microbes, often sold as a dietary supplement or used as a colorant in aquaculture and cosmetics. Investors care because its demand, production method (natural vs. synthetic), regulatory approvals, and supply costs directly affect sales, margins and growth potential—think of it as a specialty ingredient whose price and quality can make or break a product line.
photobioreactor technical
"using a 500-liter photobioreactor"
A photobioreactor is a closed, controlled system that grows photosynthetic organisms—like algae or cyanobacteria—by supplying light, nutrients, temperature control, and gas exchange. For investors, it matters because these systems determine how efficiently and predictably biological products (biofuels, animal feed, nutritional compounds, or carbon-capture biomass) can be produced at scale; think of it as a greenhouse with precise lab controls that affects output, cost and regulatory compliance.
carotenoid technical
"Astaxanthin is a naturally occurring carotenoid"
Carotenoids are natural, fat-soluble pigments produced by plants, algae and some microbes that give fruits, vegetables and seafood their yellow, orange, or red colors and often act like biological sunblock and nutrient precursors for animals. Investors care because carotenoids are used as ingredients in food, animal feed, dietary supplements, cosmetics and pharmaceuticals, so their availability, production costs, regulatory approval and consumer demand can directly affect companies’ revenues and profit margins.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

VANCOUVER, BC / ACCESS Newswire / November 17, 2026 / Pinnacle Food Group Limited (NASDAQ:PFAI) ("Pinnacle Food" or the "Company"), a technology-driven company operating at the intersection of smart farming and bioengineering, today announced that its Canadian subsidiary, Pinnacle Food Inc., has, through in-house research at its Vancouver laboratory, successfully achieved astaxanthin extraction at laboratory scale in its Haematococcus pluvialis microalgae research program.

The program's research workflow has now progressed through algal strain screening, three-stage culture expansion, stress induction and astaxanthin accumulation, and extraction of astaxanthin from the cultivated biomass. Cultivation was carried out using a 500-liter photobioreactor, followed by laboratory-scale astaxanthin extraction using an in-house extraction process. The Company considers this an early-stage milestone in its research and development process.

Astaxanthin is a naturally occurring carotenoid, and Haematococcus pluvialis is a microalga widely studied as a natural source of astaxanthin. The Company intends to continue research toward process optimization and evaluation of scale-up feasibility. The results to date are at laboratory scale, and further work is required before any assessment of commercial viability can be made. There can be no assurance that the Company's research will result in a commercially viable process or product.

"We are encouraged that our team has completed the laboratory workflow from strain screening through astaxanthin extraction," said Mr. Jiulong You, Chief Executive Officer of Pinnacle Food. "This is an early-stage research milestone. We will remain disciplined as we continue to evaluate process optimization and scale-up feasibility as part of our microalgae biomanufacturing research."

About Pinnacle Food Group Limited

Pinnacle Food Group Limited (NASDAQ:PFAI) is a technology-driven company operating at the intersection of smart farming and bioengineering. Through its "Dual-Engine" strategy, the Company seeks to combine controlled-environment agricultural technologies with precision fermentation, synthetic biology and related engineering capabilities to support the development and commercialization of high-value biological products. For more information, please visit the Company's website at www.pinnaclefoodinc.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements regarding the Company's expectations, research milestones, further process optimization and scale-up evaluation of its Haematococcus pluvialis astaxanthin program, and potential applications of astaxanthin. Forward-looking statements can be identified by words such as "anticipates," "believes," "continue," "expects," "intends," "may," "plans," "potential," "will" and similar expressions.

Forward-looking statements are based on current expectations, estimates and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Such risks and uncertainties include, among others, the early stage of the Company's microalgae research; the possibility that results achieved at laboratory scale may not be replicated or improved upon in further experiments or at larger scales; the ability to achieve commercially viable yields, purity, production costs and product quality; technical challenges in cultivation, extraction, process development and scale-up; uncertainties regarding intellectual property ownership, protection and freedom-to-operate; the receipt and maintenance of any required regulatory approvals; the availability of funding; competition; changes in market demand and pricing; and broader economic and industry conditions.

Readers are cautioned not to place undue reliance on these forward-looking statements. For a more detailed discussion of risks and uncertainties, please refer to the Company's filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

Investor Relations Contact

Dr. Yunhao Chen
Chief Financial Officer
Email: ir@pinnaclefoodinc.com

SOURCE: Pinnacle Food Group Limited



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What milestone did Pinnacle Food Group (PFAI) achieve in its astaxanthin research?

Pinnacle Food’s Canadian subsidiary achieved laboratory-scale astaxanthin extraction from cultivated Haematococcus pluvialis microalgae at its Vancouver laboratory. Cultivation used a 500-liter photobioreactor, followed by extraction using an in-house process.

Is Pinnacle Food Group’s astaxanthin process commercially viable?

Commercial viability has not yet been assessed; further work is required before that assessment can be made. Results remain at laboratory scale, and the company plans research into process optimization and scale-up feasibility.

Keep reading